Telix to Start Phase 1 Clinical Trial of Prostate Cancer Imaging Product in Japan
Telix Pharmaceutical Japan KK, a subsidiary of Telix...
Theragnostics Announces Research Collaboration with Essen University Hospital to Study THG-008 for Oncology PET Imaging
Theragnostics, a private biotech company based in UK and...
Radionuclide Therapy-Immunotherapy Slows Prostate Cancer Progression, Ups Survival
A combination of radionuclide therapy and immunotherapy...
